![](/img/cover-not-exists.png)
Treatment with soluble antigen modulates the clinical course of myelin oligodendrocyte glycoprotein (MOG)-induced EAE
A. Schubart, M. Storch, H. Lassmann, C. LiningtonVolume:
90
Year:
1998
Language:
english
DOI:
10.1016/s0165-5728(98)91678-2
File:
PDF, 126 KB
english, 1998